KIDNEY TRANSPLANT; COMPLICATIONS

This study looks at African American kidney transplant patients to compare two versions of a drug called tacrolimus—one taken once a day and the other twice a day. The goal is to see which one better keeps blood vessels healthy and flexible, which is important for long-term heart…

This study tests whether a 12-week, home-based exercise program can improve heart health in people who have had a kidney transplant. Heart problems are the leading cause of death in these patients, partly due to medications and other risk factors. Half of the 50 participants will…

This study tests whether a bone marrow transplant given after a kidney transplant can train the immune system to accept the new kidney without lifelong anti-rejection medication. About 20 adults aged 18-65 who already have a functioning kidney transplant will receive an experimen…

This study tests if using a robot for kidney transplant surgery leads to fewer problems within the first month compared to traditional open surgery. About 106 adults with kidney failure will be randomly assigned to one of the two methods. The main goal is to see if robotic surger…

This study aimed to see if a special blood filter (Seraph 100) could reduce BK virus levels in kidney transplant patients. It planned to include adults with high virus levels who already had dialysis access. However, the study was withdrawn before any participants were enrolled, …

This study tests whether teaching kidney transplant recipients to eat a whole-food plant-based diet can improve their blood pressure, blood sugar, and weight, and reduce hospital visits. About 49 adults who had a kidney transplant in the past year and have high blood pressure, hi…

This study tests whether a newer drug, letermovir, works better and causes fewer side effects than the standard drug valganciclovir for preventing CMV infection in African American kidney transplant recipients. About 30 high-risk patients will take letermovir for 6 months after t…

This study tests whether a short course of two drugs (glecaprevir/pibrentasvir and ezetimibe) can prevent hepatitis C infection in people who receive a kidney, heart, lung, or pancreas from a hepatitis C-positive donor. About 200 participants who are hepatitis C-negative and awai…

This study is testing whether measuring a specific type of immune cell (regulatory T cells) before a kidney transplant can predict if the new kidney will start working slowly or with delay. Researchers will follow 180 adult kidney transplant patients to see if these cells can ser…

This study aimed to see if sodium bicarbonate (Nephrotrans®) could reduce the risk of harmful calcium buildup in the blood of kidney transplant recipients. It planned to enroll adults who had a kidney transplant at least six months earlier. However, the study was withdrawn before…